NCT05308992

Brief Summary

Latex condoms have long been available as contraceptive devices as well as an effective means of preventing the spread of sexually transmitted infections. However, lack of adequate lubrication leads to inconsistent and incorrect condom use. The latex HydroGlyde condom has a hydrophilic coating which maintains its lubricity when in contact with water. Improved lubrication during intercourse may lead to improved user satisfaction and increased condom use which would help prevent the spread of Sexually Transmitted Infections and unwanted pregnancies. The primary objective of this study is to evaluate the preference, performance (breakage, slippage), safety (adverse events) and acceptability of a HydroGlyde prototype condom compared to a commercial latex condom with silicone lubricant. A secondary objective of this study is to compare and evaluate various lubricant activation methods for reliability, usability, and user preference.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Mar 2022

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

March 10, 2022

Completed
25 days until next milestone

First Posted

Study publicly available on registry

April 4, 2022

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2022

Completed
Last Updated

April 4, 2022

Status Verified

March 1, 2022

Enrollment Period

2 months

First QC Date

March 10, 2022

Last Update Submit

March 30, 2022

Conditions

Keywords

Condom UseLatex condomsLubrication

Outcome Measures

Primary Outcomes (1)

  • User Preference to demonstrate feasibility of the prototoype

    Couples comparing the comfort, lubrication, and experience with the HydroGlyde condom to a US leading silicone lubricated condom control. Couples will provide their feedback and experience in an online questionnaire and report which sample is most preferred.

    2-3 weeks

Study Arms (1)

Couples who use condom

OTHER

The investigator will recruit heterosexual couples who have experience using silicone-lubricated latex condoms. All couples are required to have a backup birth control option and must be monogamous to participate in the study.

Device: HydroGlyde Condom

Interventions

The latex HydroGlyde condom has a hydrophilic coating which maintains its lubricity when in contact with water. Improved lubrication during intercourse may lead to improved user satisfaction and increased condom use which would help prevent the spread of Sexually Transmitted Infections and unwanted pregnancies.

Couples who use condom

Eligibility Criteria

Age18 Years - 45 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsWe are recruiting heterosexual couples: 1 female and 1 male
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Between the ages of 18 and 45 years (inclusive)
  • Willing and able to give signed informed consent.
  • Willing to respond to questions concerning their reproductive and contraceptive history and use of condoms contained on self-administered questionnaires, online questionnaires or in-person interviews.
  • Have vaginal intercourse at least once weekly.
  • Protected against pregnancy by oral contraceptives, an intrauterine device, an implant, contraceptive injections, contraceptive patch, or sterilization (tubal ligation or vasectomy).
  • Willing to use the study products for four acts of vaginal intercourse within three weeks of study entry.
  • In a mutually monogamous relationship with their study partner for at least 6 months and be willing to remain mutually monogamous throughout study participation.
  • i. Agree not to wear any genital piercing jewelry or use sex toys while using the study condoms.
  • j. Agree not to use drugs that could enhance or diminish sexual response, including testosterone, poppers, and drugs like Viagra and Cialis when using study condoms.
  • k. Agree not to use alcohol in amounts that could enhance or diminish sexual response when using the condoms.
  • l. Agree to return any unopened condoms m. Have home access to the internet, a valid personal email for each partner and be reachable by mobile phone.
  • n. Willing to participate in either in-person visits or remote study visits conducted via videoconference and telephone and curbside exchange.
  • o. Agree to complete online questionnaires after testing each study product and group of study products.
  • p. Male partner agrees to ejaculate during vaginal intercourse. q. Willing to complete interviews by phone or video with HydroGlyde Coatings representatives.
  • r. Each partner has used 10 or more male condoms in their lifetime. s. Willing to sign a confidentiality agreement pertaining to the study condoms.

You may not qualify if:

  • Currently participating in another clinical study.
  • Female partner self-reported as pregnant.
  • Allergic to natural rubber latex or has a history of recurrent adverse events following use of latex products.
  • Known allergy or skin sensitivity to common cosmetics and/or contact lens solutions or polyvinylpyrrolidone (PVP).
  • Unable to follow instructions or strictly adhere to the study schedule.
  • At significant (high) risk of sexually transmitted infections, including human immunodeficiency virus infection, or having a medical history of recurrent, serious sexually transmitted infection (e.g. gonorrhea, syphilis, chlamydia).
  • Currently using condoms for protection against a known sexually transmitted infection.
  • Taking any internally applied medication or oral medication to treat a genital condition.
  • Male partner has had difficulty achieving or maintaining an erection, or achieving ejaculation in the last month under typical circumstances/conditions.
  • Any self-reported genital condition (e.g. itching, burning, irritation, etc.) which, in the opinion of the investigator, could affect use of the study condoms or the ability to interpret study data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Essential Access Health

Los Angeles, California, 90010, United States

Location

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2022

First Posted

April 4, 2022

Study Start

March 1, 2022

Primary Completion

April 30, 2022

Study Completion

April 30, 2022

Last Updated

April 4, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

All information will only be shared by the sponsor (HydroGlyde Coatings, LLC) and clinical investigator (Essential Access Health).

Locations